Biohaven’s ion channel drug fails again, this time in major depressive disorder
Biohaven’s ion channel drug fails again, this time in major depressive disorder
Body unavailable. Use the original source.
Biohaven’s ion channel drug fails again, this time in major depressive disorder
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.